Peripheral inflammatory biomarkers and cognitive decline in older adults with and without Alzheimer's disease: A systematic review

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Peripheral inflammatory biomarkers may play an important role in the cognitive decline of aging and incidence of Alzheimer's disease (AD); however, data from epidemiological studies present conflicting findings. The purpose of the current review was to systematically determine the current state of the science on the association between peripheral inflammatory biomarkers and cognitive decline. Articles published from January 1, 2006 to October 28, 2016 were searched using the Medline and Embase databases. Nine studies met inclusion criteria (two examined participants with AD dementia and seven examined participants without dementia). Although a wide range of peripheral inflammatory biomarkers was examined, C-reactive protein and interleukin 6 were the most studied. Findings show conflicting results for the association between peripheral inflammatory biomarkers and cognitive decline. Peripheral inflammation may harm and help the brain, and therefore, the challenge of modulating immunity will be to find ways of fine tuning inflammation to delay, prevent, or treat AD.

Original languageEnglish (US)
Pages (from-to)53-60
Number of pages8
JournalJournal of Gerontological Nursing
Volume43
Issue number12
DOIs
StatePublished - Dec 2017

PubMed: MeSH publication types

  • Journal Article
  • Review

Fingerprint Dive into the research topics of 'Peripheral inflammatory biomarkers and cognitive decline in older adults with and without Alzheimer's disease: A systematic review'. Together they form a unique fingerprint.

Cite this